Is carotid intima-media thickness a reliable clinical predictor?
Spence
J David
JD
D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D050197:Atherosclerosis / Q000188:drug therapy; D001384:Azetidines / Q000008:administration & dosage*; D002339:Carotid Arteries / Q000187:drug effects* / Q000473:pathology; D002340:Carotid Artery Diseases / Q000188:drug therapy; D003327:Coronary Disease / Q000517:prevention & control; D000069438:Ezetimibe; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D019821:Simvastatin / Q000008:administration & dosage / Q000627:therapeutic use*; D017539:Tunica Intima / Q000187:drug effects* / Q000473:pathology; D017540:Tunica Media / Q000187:drug effects* / Q000473:pathology
D000924:Anticholesteremic Agents; D001384:Azetidines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin; D000069438:Ezetimibe